Exelixis | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Amgen USD 9.18B 1.03B 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Bayer EUR 10.74B 3B 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Cytokinetics USD 66.76M 65.16M 2025-06
Eisai JPY 202.65B 14.41B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Exelixis USD 568.3M 12.9M 2025-06
Genmab DKK 5.86B 580M 2025-06
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.81B 280M 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 14.05B 821M 2025-06
Pfizer USD 14.7B 980M 2025-06
Sanofi EUR 11.26B 3.5B 2024-12
Takeda JPY 1.11T 60B 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Xencor USD 43.61M 10.88M 2025-06


Exelixis Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.